Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $1.15B | 0.55% |
30,628,500
+4,524,100
| +17% | +$165M |
|
27
PUT
Alphabet (Google) Class A
GOOGL
$4.22T
| $1.12B | 0.54% |
27,908,000
-1,092,000
| -4% | -$42.7M |
|
28
Bank of America
BAC
$431B
| $1B | 0.48% |
64,075,762
-8,455,316
| -12% | -$126M |
|
|
29
PUT
Gilead Sciences
GILD
$181B
| $932M | 0.45% |
11,785,700
+3,961,900
| +51% | +$322M |
|
30
CALL
Kinder Morgan
KMI
$69B
| $924M | 0.45% |
39,941,700
-1,234,000
| -3% | -$26.1M |
|
|
31
CALL
SPDR Gold Trust
GLD
$152B
| $866M | 0.42% |
6,889,500
-1,776,000
| -20% | -$226M |
|
32
PUT
Alibaba
BABA
$286B
| $850M | 0.41% |
8,035,500
+1,789,900
| +29% | +$166M |
|
33
CALL
GE Aerospace
GE
$361B
| $830M | 0.4% |
5,848,903
+337,574
| +6% | +$50.4M |
|
34
CALL
Visa
V
$693B
| $779M | 0.38% |
9,414,300
-969,300
| -9% | -$77.6M |
|
35
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$45.5B
| $753M | 0.36% |
5,474,300
-5,283,100
| -49% | -$733M |
|
36
PUT
Netflix
NFLX
$331B
| $745M | 0.36% |
75,597,000
+12,693,000
| +20% | +$121M |
|
37
CALL
Citigroup
C
$221B
| $742M | 0.36% |
15,710,600
-1,229,800
| -7% | -$55.9M |
|
|
AGN
38
PUT
DELISTED
Allergan plc
AGN
| $719M | 0.35% |
3,120,800
-981,700
| -24% | -$240M |
|
|
VXX
39
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $713M | 0.34% |
5,235,500
+3,664,769
| +233% | +$586M |
|
|
VXX
40
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $713M | 0.34% |
5,234,975
+4,055,781
| +344% | +$648M |
|
|
41
CALL
Procter & Gamble
PG
$336B
| $707M | 0.34% |
7,874,200
+2,474,700
| +46% | +$215M |
|
|
42
Gilead Sciences
GILD
$181B
| $690M | 0.33% |
8,716,894
+4,665,666
| +115% | +$379M |
|
43
PUT
iShares MSCI EAFE ETF
EFA
$80B
| $684M | 0.33% |
11,570,500
+515,500
| +5% | +$29.9M |
|
44
CALL
ExxonMobil
XOM
$679B
| $664M | 0.32% |
7,608,000
+59,300
| +0.8% | +$5.26M |
|
45
CALL
United Parcel Service
UPS
$86.8B
| $634M | 0.31% |
5,793,800
+1,128,000
| +24% | +$123M |
|
|
46
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $611M | 0.3% |
16,318,600
-7,513,900
| -32% | -$275M |
|
|
47
CALL
Netflix
NFLX
$331B
| $590M | 0.28% |
59,842,000
-16,871,000
| -22% | -$161M |
|
48
CALL
JPMorgan Chase
JPM
$935B
| $554M | 0.27% |
8,314,600
+398,800
| +5% | +$26M |
|
49
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $554M | 0.27% |
14,565,300
-3,211,500
| -18% | -$118M |
|
|
50
PUT
Citigroup
C
$221B
| $550M | 0.27% |
11,639,200
-8,652,600
| -43% | -$394M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.